12D miR HR13_24
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr1i3
|
ENSMUSG00000005677.8 | nuclear receptor subfamily 1, group I, member 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nr1i3 | mm10_v2_chr1_+_171214013_171214045 | -0.75 | 7.3e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_128206346 | 4.19 |
ENSMUST00000033049.7
|
Cox6a2
|
cytochrome c oxidase subunit VIa polypeptide 2 |
chr6_-_5256226 | 3.99 |
ENSMUST00000125686.1
ENSMUST00000031773.2 |
Pon3
|
paraoxonase 3 |
chr6_+_90619241 | 3.46 |
ENSMUST00000032177.8
|
Slc41a3
|
solute carrier family 41, member 3 |
chr7_-_101864093 | 2.90 |
ENSMUST00000106981.1
|
Folr1
|
folate receptor 1 (adult) |
chr11_+_68556186 | 2.88 |
ENSMUST00000053211.6
|
Mfsd6l
|
major facilitator superfamily domain containing 6-like |
chr16_+_5007306 | 2.75 |
ENSMUST00000178155.2
ENSMUST00000184256.1 ENSMUST00000185147.1 |
Smim22
|
small integral membrane protein 22 |
chr16_+_5007283 | 2.62 |
ENSMUST00000184439.1
|
Smim22
|
small integral membrane protein 22 |
chr4_-_19922599 | 2.40 |
ENSMUST00000029900.5
|
Atp6v0d2
|
ATPase, H+ transporting, lysosomal V0 subunit D2 |
chr15_-_66560997 | 2.28 |
ENSMUST00000048372.5
|
Tmem71
|
transmembrane protein 71 |
chr11_+_69964758 | 2.08 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chr4_+_143349757 | 1.95 |
ENSMUST00000052458.2
|
Lrrc38
|
leucine rich repeat containing 38 |
chr16_+_32756336 | 1.94 |
ENSMUST00000135753.1
|
Muc4
|
mucin 4 |
chr7_+_28440927 | 1.93 |
ENSMUST00000078845.6
|
Gmfg
|
glia maturation factor, gamma |
chr7_-_46179929 | 1.93 |
ENSMUST00000033123.6
|
Abcc8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
chr9_-_45204083 | 1.85 |
ENSMUST00000034599.8
|
Tmprss4
|
transmembrane protease, serine 4 |
chr4_+_128058962 | 1.72 |
ENSMUST00000184063.1
|
Csmd2
|
CUB and Sushi multiple domains 2 |
chr11_-_3931960 | 1.71 |
ENSMUST00000109990.1
ENSMUST00000020710.4 ENSMUST00000109989.3 ENSMUST00000109991.1 ENSMUST00000109993.2 |
Tcn2
|
transcobalamin 2 |
chr3_+_28697901 | 1.68 |
ENSMUST00000029240.7
|
Slc2a2
|
solute carrier family 2 (facilitated glucose transporter), member 2 |
chr11_+_69965396 | 1.60 |
ENSMUST00000018713.6
|
Cldn7
|
claudin 7 |
chr13_-_3945349 | 1.58 |
ENSMUST00000058610.7
|
Ucn3
|
urocortin 3 |
chr2_-_93452679 | 1.58 |
ENSMUST00000111257.1
ENSMUST00000145553.1 |
Cd82
|
CD82 antigen |
chr7_-_66427469 | 1.55 |
ENSMUST00000015278.7
|
Aldh1a3
|
aldehyde dehydrogenase family 1, subfamily A3 |
chr2_-_3422608 | 1.53 |
ENSMUST00000064685.7
|
Meig1
|
meiosis expressed gene 1 |
chr7_-_101868667 | 1.52 |
ENSMUST00000150184.1
|
Folr1
|
folate receptor 1 (adult) |
chr3_+_105870898 | 1.45 |
ENSMUST00000010279.5
|
Adora3
|
adenosine A3 receptor |
chr4_+_102421518 | 1.44 |
ENSMUST00000106904.2
|
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr4_+_104766334 | 1.41 |
ENSMUST00000065072.6
|
C8b
|
complement component 8, beta polypeptide |
chr9_+_46998931 | 1.34 |
ENSMUST00000178065.1
|
Gm4791
|
predicted gene 4791 |
chr11_+_113619318 | 1.33 |
ENSMUST00000146390.2
ENSMUST00000106630.1 |
Sstr2
|
somatostatin receptor 2 |
chr11_-_102107822 | 1.32 |
ENSMUST00000177304.1
ENSMUST00000017455.8 |
Pyy
|
peptide YY |
chr2_-_129699833 | 1.31 |
ENSMUST00000028883.5
|
Pdyn
|
prodynorphin |
chr4_-_141846359 | 1.31 |
ENSMUST00000037059.10
|
Ctrc
|
chymotrypsin C (caldecrin) |
chr9_-_121792478 | 1.31 |
ENSMUST00000035110.4
|
Hhatl
|
hedgehog acyltransferase-like |
chr4_+_104766308 | 1.30 |
ENSMUST00000031663.3
|
C8b
|
complement component 8, beta polypeptide |
chr16_+_17331371 | 1.28 |
ENSMUST00000023450.6
ENSMUST00000161034.1 |
Serpind1
|
serine (or cysteine) peptidase inhibitor, clade D, member 1 |
chr17_+_57062231 | 1.28 |
ENSMUST00000097299.3
ENSMUST00000169543.1 ENSMUST00000163763.1 |
Crb3
|
crumbs homolog 3 (Drosophila) |
chr8_+_70724064 | 1.27 |
ENSMUST00000034307.7
ENSMUST00000110095.2 |
Pde4c
|
phosphodiesterase 4C, cAMP specific |
chr2_-_32387760 | 1.26 |
ENSMUST00000050785.8
|
Lcn2
|
lipocalin 2 |
chrX_+_107816477 | 1.24 |
ENSMUST00000143975.1
ENSMUST00000144695.1 ENSMUST00000167154.1 |
Fam46d
|
family with sequence similarity 46, member D |
chr17_-_31144271 | 1.24 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr1_+_166254095 | 1.23 |
ENSMUST00000111416.1
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr12_+_58211772 | 1.23 |
ENSMUST00000110671.2
ENSMUST00000044299.2 |
Sstr1
|
somatostatin receptor 1 |
chr17_+_21691860 | 1.22 |
ENSMUST00000072133.4
|
Gm10226
|
predicted gene 10226 |
chr10_+_73821857 | 1.20 |
ENSMUST00000177128.1
ENSMUST00000064562.7 ENSMUST00000129404.2 ENSMUST00000105426.3 ENSMUST00000131321.2 ENSMUST00000126920.2 ENSMUST00000147189.2 ENSMUST00000105424.3 ENSMUST00000092420.6 ENSMUST00000105429.3 ENSMUST00000131724.2 ENSMUST00000152655.2 ENSMUST00000151116.2 ENSMUST00000155701.2 ENSMUST00000152819.2 ENSMUST00000125517.2 ENSMUST00000124046.1 ENSMUST00000149977.2 ENSMUST00000146682.1 ENSMUST00000177107.1 |
Pcdh15
|
protocadherin 15 |
chr3_+_145292472 | 1.20 |
ENSMUST00000029848.4
ENSMUST00000139001.1 |
Col24a1
|
collagen, type XXIV, alpha 1 |
chr11_-_61719946 | 1.20 |
ENSMUST00000151780.1
ENSMUST00000148584.1 |
Slc5a10
|
solute carrier family 5 (sodium/glucose cotransporter), member 10 |
chr16_+_30008657 | 1.20 |
ENSMUST00000181485.1
|
4632428C04Rik
|
RIKEN cDNA 4632428C04 gene |
chr16_+_23290464 | 1.20 |
ENSMUST00000115335.1
|
St6gal1
|
beta galactoside alpha 2,6 sialyltransferase 1 |
chr15_+_100353149 | 1.20 |
ENSMUST00000075675.5
ENSMUST00000088142.5 ENSMUST00000176287.1 |
AB099516
Mettl7a2
|
cDNA sequence AB099516 methyltransferase like 7A2 |
chr2_+_174760619 | 1.19 |
ENSMUST00000029030.2
|
Edn3
|
endothelin 3 |
chr13_-_71963713 | 1.18 |
ENSMUST00000077337.8
|
Irx1
|
Iroquois related homeobox 1 (Drosophila) |
chr1_-_84696182 | 1.17 |
ENSMUST00000049126.6
|
Dner
|
delta/notch-like EGF-related receptor |
chr11_+_54902743 | 1.16 |
ENSMUST00000082430.3
|
Gpx3
|
glutathione peroxidase 3 |
chr17_+_69439326 | 1.16 |
ENSMUST00000169935.1
|
A330050F15Rik
|
RIKEN cDNA A330050F15 gene |
chr4_+_106733883 | 1.14 |
ENSMUST00000047620.2
|
Fam151a
|
family with sequence simliarity 151, member A |
chr2_-_144332146 | 1.13 |
ENSMUST00000037423.3
|
Ovol2
|
ovo-like 2 (Drosophila) |
chr2_-_62412219 | 1.13 |
ENSMUST00000047812.7
|
Dpp4
|
dipeptidylpeptidase 4 |
chr7_-_3677509 | 1.10 |
ENSMUST00000038743.8
|
Tmc4
|
transmembrane channel-like gene family 4 |
chr2_+_24336846 | 1.10 |
ENSMUST00000114487.2
|
Il1rn
|
interleukin 1 receptor antagonist |
chr16_-_45492962 | 1.10 |
ENSMUST00000114585.2
|
Gm609
|
predicted gene 609 |
chr2_-_3422576 | 1.10 |
ENSMUST00000144584.1
|
Meig1
|
meiosis expressed gene 1 |
chr2_+_170731807 | 1.09 |
ENSMUST00000029075.4
|
Dok5
|
docking protein 5 |
chr11_+_54902917 | 1.08 |
ENSMUST00000149324.1
|
Gpx3
|
glutathione peroxidase 3 |
chr8_+_10006656 | 1.07 |
ENSMUST00000033892.7
|
Tnfsf13b
|
tumor necrosis factor (ligand) superfamily, member 13b |
chr17_+_5492558 | 1.06 |
ENSMUST00000089185.4
|
Zdhhc14
|
zinc finger, DHHC domain containing 14 |
chr6_+_90550789 | 1.05 |
ENSMUST00000130418.1
ENSMUST00000032175.8 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr10_-_75797528 | 1.04 |
ENSMUST00000120177.1
|
Gstt1
|
glutathione S-transferase, theta 1 |
chr10_+_127866457 | 1.04 |
ENSMUST00000092058.3
|
BC089597
|
cDNA sequence BC089597 |
chr1_-_20617992 | 1.00 |
ENSMUST00000088448.5
|
Pkhd1
|
polycystic kidney and hepatic disease 1 |
chr4_-_63154130 | 1.00 |
ENSMUST00000030041.4
|
Ambp
|
alpha 1 microglobulin/bikunin |
chr2_-_172043466 | 0.99 |
ENSMUST00000087950.3
|
Cbln4
|
cerebellin 4 precursor protein |
chr19_-_6980420 | 0.99 |
ENSMUST00000070878.8
ENSMUST00000177752.1 |
Fkbp2
|
FK506 binding protein 2 |
chr11_+_26387194 | 0.98 |
ENSMUST00000109509.1
ENSMUST00000136830.1 |
Fancl
|
Fanconi anemia, complementation group L |
chr4_+_110397661 | 0.97 |
ENSMUST00000106589.2
ENSMUST00000106587.2 ENSMUST00000106591.1 ENSMUST00000106592.1 |
Agbl4
|
ATP/GTP binding protein-like 4 |
chr6_+_41302265 | 0.97 |
ENSMUST00000031913.4
|
Try4
|
trypsin 4 |
chr4_+_110397764 | 0.96 |
ENSMUST00000097920.2
ENSMUST00000080744.6 |
Agbl4
|
ATP/GTP binding protein-like 4 |
chr7_+_44225430 | 0.96 |
ENSMUST00000075162.3
|
Klk1
|
kallikrein 1 |
chr6_+_96115249 | 0.96 |
ENSMUST00000075080.5
|
Fam19a1
|
family with sequence similarity 19, member A1 |
chr15_-_101370125 | 0.94 |
ENSMUST00000077196.4
|
Krt80
|
keratin 80 |
chr13_+_38151343 | 0.94 |
ENSMUST00000124830.1
|
Dsp
|
desmoplakin |
chr18_-_32139570 | 0.94 |
ENSMUST00000171765.1
|
Proc
|
protein C |
chr8_+_95320440 | 0.94 |
ENSMUST00000162294.1
|
Tepp
|
testis, prostate and placenta expressed |
chr7_+_141078188 | 0.93 |
ENSMUST00000106039.2
|
Pkp3
|
plakophilin 3 |
chr19_+_52264323 | 0.92 |
ENSMUST00000039652.4
|
Ins1
|
insulin I |
chr6_-_5496296 | 0.92 |
ENSMUST00000019721.4
|
Pdk4
|
pyruvate dehydrogenase kinase, isoenzyme 4 |
chr6_+_108783059 | 0.92 |
ENSMUST00000032196.6
|
Arl8b
|
ADP-ribosylation factor-like 8B |
chr7_+_25306085 | 0.91 |
ENSMUST00000119703.1
ENSMUST00000108409.1 |
Tmem145
|
transmembrane protein 145 |
chr6_-_113719880 | 0.91 |
ENSMUST00000064993.5
|
Ghrl
|
ghrelin |
chr4_-_62519885 | 0.91 |
ENSMUST00000107444.1
ENSMUST00000030090.3 |
Alad
|
aminolevulinate, delta-, dehydratase |
chr7_+_122219469 | 0.90 |
ENSMUST00000033152.4
|
Chp2
|
calcineurin-like EF hand protein 2 |
chr15_-_67113909 | 0.89 |
ENSMUST00000092640.5
|
St3gal1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
chr1_+_134193432 | 0.89 |
ENSMUST00000038445.6
|
Mybph
|
myosin binding protein H |
chr7_+_30184160 | 0.89 |
ENSMUST00000098594.2
|
Cox7a1
|
cytochrome c oxidase subunit VIIa 1 |
chr6_-_47813512 | 0.89 |
ENSMUST00000077290.7
|
Pdia4
|
protein disulfide isomerase associated 4 |
chr1_-_9967932 | 0.89 |
ENSMUST00000185184.1
|
Tcf24
|
transcription factor 24 |
chr6_+_139736895 | 0.89 |
ENSMUST00000111868.3
|
Pik3c2g
|
phosphatidylinositol 3-kinase, C2 domain containing, gamma polypeptide |
chr6_+_42261957 | 0.88 |
ENSMUST00000095987.3
|
Tmem139
|
transmembrane protein 139 |
chr17_-_36168507 | 0.87 |
ENSMUST00000097335.3
ENSMUST00000173353.1 |
Gm8909
|
predicted gene 8909 |
chr10_+_97479470 | 0.87 |
ENSMUST00000105287.3
|
Dcn
|
decorin |
chr14_-_34355383 | 0.87 |
ENSMUST00000052126.5
|
Fam25c
|
family with sequence similarity 25, member C |
chr1_-_9962809 | 0.87 |
ENSMUST00000097824.2
|
Gm10567
|
predicted gene 10567 |
chr17_+_30901811 | 0.86 |
ENSMUST00000114574.1
|
Glp1r
|
glucagon-like peptide 1 receptor |
chr5_+_16553488 | 0.85 |
ENSMUST00000030683.3
|
Hgf
|
hepatocyte growth factor |
chr17_-_24689901 | 0.85 |
ENSMUST00000007236.4
|
Syngr3
|
synaptogyrin 3 |
chr12_-_17176888 | 0.85 |
ENSMUST00000170580.1
|
Kcnf1
|
potassium voltage-gated channel, subfamily F, member 1 |
chr10_-_127041513 | 0.85 |
ENSMUST00000116231.2
|
Mettl21b
|
methyltransferase like 21B |
chr13_+_24845122 | 0.84 |
ENSMUST00000006893.8
|
D130043K22Rik
|
RIKEN cDNA D130043K22 gene |
chr1_+_16688405 | 0.83 |
ENSMUST00000026881.4
|
Ly96
|
lymphocyte antigen 96 |
chr15_+_10223974 | 0.83 |
ENSMUST00000128450.1
ENSMUST00000148257.1 ENSMUST00000128921.1 |
Prlr
|
prolactin receptor |
chr12_-_113422730 | 0.83 |
ENSMUST00000177715.1
ENSMUST00000103426.1 |
Ighm
|
immunoglobulin heavy constant mu |
chr8_+_76902277 | 0.83 |
ENSMUST00000109912.1
ENSMUST00000128862.1 ENSMUST00000109911.1 |
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr15_+_10314102 | 0.83 |
ENSMUST00000127467.1
|
Prlr
|
prolactin receptor |
chrX_+_164140447 | 0.82 |
ENSMUST00000073973.4
|
Ace2
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
chr4_-_43653560 | 0.82 |
ENSMUST00000107870.2
|
Spag8
|
sperm associated antigen 8 |
chr4_-_45532470 | 0.82 |
ENSMUST00000147448.1
|
Shb
|
src homology 2 domain-containing transforming protein B |
chr8_-_54529951 | 0.82 |
ENSMUST00000067476.8
|
Spcs3
|
signal peptidase complex subunit 3 homolog (S. cerevisiae) |
chr17_-_28560704 | 0.82 |
ENSMUST00000114785.1
ENSMUST00000025062.3 |
Clps
|
colipase, pancreatic |
chr4_-_141846277 | 0.82 |
ENSMUST00000105781.1
|
Ctrc
|
chymotrypsin C (caldecrin) |
chr1_-_157108632 | 0.81 |
ENSMUST00000118207.1
ENSMUST00000027884.6 ENSMUST00000121911.1 |
Tex35
|
testis expressed 35 |
chr1_+_192190771 | 0.81 |
ENSMUST00000078470.5
ENSMUST00000110844.1 |
Kcnh1
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
chr19_-_7607103 | 0.81 |
ENSMUST00000079902.5
ENSMUST00000099729.3 ENSMUST00000159983.1 |
Lgals12
|
lectin, galactose binding, soluble 12 |
chr8_-_111691002 | 0.81 |
ENSMUST00000034435.5
|
Ctrb1
|
chymotrypsinogen B1 |
chr10_+_80264942 | 0.81 |
ENSMUST00000105362.1
ENSMUST00000105361.3 |
Dazap1
|
DAZ associated protein 1 |
chr9_+_111019284 | 0.81 |
ENSMUST00000035077.3
|
Ltf
|
lactotransferrin |
chr7_-_79793788 | 0.80 |
ENSMUST00000032760.5
|
Mesp1
|
mesoderm posterior 1 |
chr18_-_44662251 | 0.80 |
ENSMUST00000164666.1
|
Mcc
|
mutated in colorectal cancers |
chr9_-_21989427 | 0.80 |
ENSMUST00000045726.6
|
Rgl3
|
ral guanine nucleotide dissociation stimulator-like 3 |
chr8_+_105427634 | 0.80 |
ENSMUST00000067305.6
|
Lrrc36
|
leucine rich repeat containing 36 |
chr15_+_100334929 | 0.80 |
ENSMUST00000075420.4
|
Mettl7a3
|
methyltransferase like 7A3 |
chr17_+_57249450 | 0.79 |
ENSMUST00000019631.9
|
Trip10
|
thyroid hormone receptor interactor 10 |
chr10_+_87521920 | 0.79 |
ENSMUST00000142088.1
|
Pah
|
phenylalanine hydroxylase |
chr11_+_9048575 | 0.78 |
ENSMUST00000043285.4
|
Gm11992
|
predicted gene 11992 |
chr11_-_3452355 | 0.78 |
ENSMUST00000064364.2
ENSMUST00000077078.5 |
Rnf185
|
ring finger protein 185 |
chr18_-_34007206 | 0.78 |
ENSMUST00000025234.5
|
Epb4.1l4a
|
erythrocyte protein band 4.1-like 4a |
chr17_-_34959232 | 0.78 |
ENSMUST00000165202.1
ENSMUST00000172753.1 |
Hspa1b
|
heat shock protein 1B |
chr5_+_91139591 | 0.77 |
ENSMUST00000031325.4
|
Areg
|
amphiregulin |
chr11_+_61065798 | 0.77 |
ENSMUST00000041944.2
ENSMUST00000108717.2 |
Kcnj12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
chr7_-_125349745 | 0.77 |
ENSMUST00000061823.1
|
4933440M02Rik
|
RIKEN cDNA 4933440M02 gene |
chr1_+_74409376 | 0.77 |
ENSMUST00000027366.6
|
Vil1
|
villin 1 |
chr14_+_41131777 | 0.76 |
ENSMUST00000022314.3
ENSMUST00000170719.1 |
Sftpa1
|
surfactant associated protein A1 |
chr11_+_106374820 | 0.76 |
ENSMUST00000106816.1
|
2310007L24Rik
|
RIKEN cDNA 2310007L24 gene |
chr7_+_44216456 | 0.76 |
ENSMUST00000074359.2
|
Klk1b5
|
kallikrein 1-related peptidase b5 |
chr16_+_32735886 | 0.76 |
ENSMUST00000132475.1
ENSMUST00000096106.3 |
Muc4
|
mucin 4 |
chr17_+_17831004 | 0.76 |
ENSMUST00000172097.2
|
4930546H06Rik
|
RIKEN cDNA 4930546H06 gene |
chr16_-_38294774 | 0.75 |
ENSMUST00000023504.4
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2 |
chr11_-_3931789 | 0.75 |
ENSMUST00000109992.1
ENSMUST00000109988.1 |
Tcn2
|
transcobalamin 2 |
chr8_+_54954728 | 0.75 |
ENSMUST00000033915.7
|
Gpm6a
|
glycoprotein m6a |
chr15_+_99393574 | 0.75 |
ENSMUST00000162624.1
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr16_+_97356721 | 0.75 |
ENSMUST00000047275.6
|
Bace2
|
beta-site APP-cleaving enzyme 2 |
chr17_+_6673610 | 0.75 |
ENSMUST00000097430.2
|
Sytl3
|
synaptotagmin-like 3 |
chr5_+_30466044 | 0.75 |
ENSMUST00000031078.3
ENSMUST00000114743.1 |
1700001C02Rik
|
RIKEN cDNA 1700001C02 gene |
chr5_+_149439706 | 0.74 |
ENSMUST00000031667.4
|
Tex26
|
testis expressed 26 |
chr13_+_30136529 | 0.74 |
ENSMUST00000152798.1
|
Mboat1
|
membrane bound O-acyltransferase domain containing 1 |
chr4_+_120666562 | 0.74 |
ENSMUST00000094814.4
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr13_+_108214389 | 0.74 |
ENSMUST00000022207.8
|
Elovl7
|
ELOVL family member 7, elongation of long chain fatty acids (yeast) |
chr18_-_61014199 | 0.74 |
ENSMUST00000025520.8
|
Slc6a7
|
solute carrier family 6 (neurotransmitter transporter, L-proline), member 7 |
chr15_+_99393610 | 0.74 |
ENSMUST00000159531.1
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr19_+_58759700 | 0.74 |
ENSMUST00000026081.3
|
Pnliprp2
|
pancreatic lipase-related protein 2 |
chr17_+_47436731 | 0.74 |
ENSMUST00000150819.2
|
AI661453
|
expressed sequence AI661453 |
chr16_-_11134624 | 0.73 |
ENSMUST00000038424.7
|
Txndc11
|
thioredoxin domain containing 11 |
chr18_+_77185815 | 0.73 |
ENSMUST00000079618.4
|
St8sia5
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
chr7_+_28437447 | 0.72 |
ENSMUST00000108292.2
ENSMUST00000108289.1 |
Gmfg
|
glia maturation factor, gamma |
chr5_+_122707546 | 0.72 |
ENSMUST00000081554.6
ENSMUST00000031429.7 ENSMUST00000139631.1 ENSMUST00000142664.1 |
P2rx4
|
purinergic receptor P2X, ligand-gated ion channel 4 |
chr11_+_117115195 | 0.72 |
ENSMUST00000103026.3
ENSMUST00000090433.5 |
Sec14l1
|
SEC14-like 1 (S. cerevisiae) |
chr17_-_57105916 | 0.72 |
ENSMUST00000112915.2
|
Gm11110
|
predicted gene 11110 |
chr5_+_115466234 | 0.71 |
ENSMUST00000145785.1
ENSMUST00000031495.4 ENSMUST00000112071.1 ENSMUST00000125568.1 |
Pla2g1b
|
phospholipase A2, group IB, pancreas |
chr7_-_126463100 | 0.71 |
ENSMUST00000032974.6
|
Atp2a1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
chr19_+_11404735 | 0.71 |
ENSMUST00000153546.1
|
Ms4a4c
|
membrane-spanning 4-domains, subfamily A, member 4C |
chr15_-_88819279 | 0.70 |
ENSMUST00000043087.8
ENSMUST00000162183.1 |
Alg12
|
asparagine-linked glycosylation 12 (alpha-1,6-mannosyltransferase) |
chr7_+_45617575 | 0.70 |
ENSMUST00000008605.5
|
Fut1
|
fucosyltransferase 1 |
chr2_+_180456234 | 0.70 |
ENSMUST00000038259.6
|
Slco4a1
|
solute carrier organic anion transporter family, member 4a1 |
chr19_+_22139028 | 0.70 |
ENSMUST00000099569.2
ENSMUST00000087576.4 ENSMUST00000074770.5 |
Trpm3
|
transient receptor potential cation channel, subfamily M, member 3 |
chr16_-_32797413 | 0.70 |
ENSMUST00000115116.1
ENSMUST00000041123.8 |
Muc20
|
mucin 20 |
chr2_-_24049389 | 0.70 |
ENSMUST00000051416.5
|
Hnmt
|
histamine N-methyltransferase |
chr5_-_108795352 | 0.70 |
ENSMUST00000004943.1
|
Tmed11
|
transmembrane emp24 protein transport domain containing |
chr4_+_118526986 | 0.69 |
ENSMUST00000106367.1
|
2610528J11Rik
|
RIKEN cDNA 2610528J11 gene |
chr15_+_7129557 | 0.69 |
ENSMUST00000067190.5
ENSMUST00000164529.1 |
Lifr
|
leukemia inhibitory factor receptor |
chr6_-_18514802 | 0.69 |
ENSMUST00000090601.5
|
Cttnbp2
|
cortactin binding protein 2 |
chr16_+_33062512 | 0.69 |
ENSMUST00000023497.2
|
Lmln
|
leishmanolysin-like (metallopeptidase M8 family) |
chr4_+_40473130 | 0.69 |
ENSMUST00000179526.1
|
Tmem215
|
transmembrane protein 215 |
chr7_-_19822698 | 0.68 |
ENSMUST00000120537.1
|
Bcl3
|
B cell leukemia/lymphoma 3 |
chr9_-_21592805 | 0.68 |
ENSMUST00000034700.7
ENSMUST00000180365.1 ENSMUST00000078572.7 |
Yipf2
|
Yip1 domain family, member 2 |
chr3_+_138065052 | 0.68 |
ENSMUST00000163080.2
|
1110002E22Rik
|
RIKEN cDNA 1110002E22 gene |
chr1_-_171437288 | 0.68 |
ENSMUST00000181499.1
|
Gm26641
|
predicted gene, 26641 |
chr3_-_89093358 | 0.68 |
ENSMUST00000090929.5
ENSMUST00000052539.6 |
Rusc1
|
RUN and SH3 domain containing 1 |
chr17_+_70561739 | 0.68 |
ENSMUST00000097288.2
|
Dlgap1
|
discs, large (Drosophila) homolog-associated protein 1 |
chrX_-_106011874 | 0.68 |
ENSMUST00000033583.7
ENSMUST00000151689.1 |
Magt1
|
magnesium transporter 1 |
chr7_-_141100526 | 0.68 |
ENSMUST00000097958.2
|
Sigirr
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr8_-_64733534 | 0.67 |
ENSMUST00000141021.1
|
Sc4mol
|
sterol-C4-methyl oxidase-like |
chr10_+_87521795 | 0.67 |
ENSMUST00000020241.8
|
Pah
|
phenylalanine hydroxylase |
chr9_+_118506226 | 0.67 |
ENSMUST00000084820.4
|
Golga4
|
golgi autoantigen, golgin subfamily a, 4 |
chr15_+_83563571 | 0.67 |
ENSMUST00000047419.6
|
Tspo
|
translocator protein |
chr5_-_131616599 | 0.67 |
ENSMUST00000161804.1
|
Auts2
|
autism susceptibility candidate 2 |
chr2_-_66568312 | 0.66 |
ENSMUST00000112354.1
|
Scn9a
|
sodium channel, voltage-gated, type IX, alpha |
chr17_-_47400584 | 0.66 |
ENSMUST00000059348.7
|
Guca1a
|
guanylate cyclase activator 1a (retina) |
chr8_+_119437118 | 0.66 |
ENSMUST00000152420.1
ENSMUST00000098365.3 |
Osgin1
|
oxidative stress induced growth inhibitor 1 |
chr1_-_183345296 | 0.66 |
ENSMUST00000109158.3
|
Mia3
|
melanoma inhibitory activity 3 |
chr2_+_58755177 | 0.66 |
ENSMUST00000102755.3
|
Upp2
|
uridine phosphorylase 2 |
chr14_-_57398483 | 0.65 |
ENSMUST00000022517.7
|
Cryl1
|
crystallin, lambda 1 |
chr7_+_19083842 | 0.65 |
ENSMUST00000032568.7
ENSMUST00000122999.1 ENSMUST00000108473.3 ENSMUST00000108474.1 |
Dmpk
|
dystrophia myotonica-protein kinase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 4.0 | GO:0009804 | coumarin metabolic process(GO:0009804) phenylpropanoid catabolic process(GO:0046271) |
1.1 | 3.2 | GO:0071846 | actin filament debranching(GO:0071846) |
0.7 | 2.1 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.6 | 1.9 | GO:0009095 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
0.6 | 1.8 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.5 | 1.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.5 | 5.2 | GO:0060974 | cell migration involved in heart formation(GO:0060974) |
0.5 | 1.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 2.9 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.5 | 1.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 1.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.4 | 2.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 1.6 | GO:1990743 | protein sialylation(GO:1990743) |
0.4 | 1.1 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.4 | 1.4 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.3 | 1.0 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.3 | 1.0 | GO:0018900 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.3 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 2.0 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 1.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 1.0 | GO:1904349 | positive regulation of small intestine smooth muscle contraction(GO:1904349) |
0.3 | 1.6 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.3 | 4.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 1.5 | GO:0031438 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.3 | 0.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.3 | 0.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 1.2 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.3 | 3.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 0.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 0.8 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.3 | 1.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 0.8 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.3 | 1.6 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.3 | 0.5 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.5 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.3 | 1.0 | GO:1902896 | terminal web assembly(GO:1902896) |
0.3 | 0.5 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.2 | 2.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 1.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 1.0 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.2 | 4.4 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 0.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 0.7 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 1.4 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.9 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.2 | 0.7 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.2 | 1.8 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.2 | 1.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.2 | 0.7 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.2 | 0.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 1.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 0.7 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.2 | 1.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 1.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.2 | 0.6 | GO:1905204 | septum secundum development(GO:0003285) cardiac muscle tissue regeneration(GO:0061026) negative regulation of connective tissue replacement(GO:1905204) |
0.2 | 0.6 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.2 | 0.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 1.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.8 | GO:0060376 | positive regulation of mast cell differentiation(GO:0060376) |
0.2 | 0.6 | GO:2000978 | STAT protein import into nucleus(GO:0007262) negative regulation of forebrain neuron differentiation(GO:2000978) |
0.2 | 1.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.2 | 1.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.2 | 0.6 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.2 | 0.6 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.2 | 0.8 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.2 | 1.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 2.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 1.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 1.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 1.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 0.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.6 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 0.7 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 1.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 2.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.7 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 0.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 0.5 | GO:0046370 | fructose biosynthetic process(GO:0046370) |
0.2 | 0.9 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.5 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 0.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 0.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.2 | 0.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.2 | 0.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.6 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.2 | 0.5 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 0.5 | GO:0072302 | negative regulation of metanephric glomerulus development(GO:0072299) regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.2 | 1.5 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 1.8 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 0.5 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.2 | 1.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 2.1 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.2 | 0.5 | GO:0009726 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.2 | 0.6 | GO:0021660 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.2 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 1.4 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 1.7 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.9 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.4 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 0.3 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.1 | 0.9 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.6 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.4 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.1 | 1.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 1.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 0.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.4 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.1 | 0.1 | GO:1900141 | regulation of oligodendrocyte apoptotic process(GO:1900141) negative regulation of oligodendrocyte apoptotic process(GO:1900142) |
0.1 | 0.6 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 1.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.4 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 1.5 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 3.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.4 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.1 | 0.4 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.1 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.5 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 0.5 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.4 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 0.5 | GO:1902477 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 0.5 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.4 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.4 | GO:1901738 | regulation of isoprenoid metabolic process(GO:0019747) regulation of vitamin A metabolic process(GO:1901738) |
0.1 | 0.7 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
0.1 | 1.0 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 8.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.6 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.5 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
0.1 | 0.5 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.4 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.1 | 0.3 | GO:0071226 | cellular response to molecule of fungal origin(GO:0071226) |
0.1 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.5 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.1 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.4 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.1 | 0.3 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.1 | 0.9 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.5 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 0.5 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.3 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.1 | 0.4 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.1 | 0.5 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.3 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 1.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 1.1 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.2 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.1 | 0.4 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.1 | 1.0 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.1 | 0.4 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 0.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.6 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.1 | 0.4 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.1 | 0.3 | GO:2001293 | fatty-acyl-CoA biosynthetic process(GO:0046949) malonyl-CoA metabolic process(GO:2001293) |
0.1 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.9 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.5 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.3 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.1 | 0.3 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.1 | 0.7 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.4 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.1 | 0.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 1.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.3 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.4 | GO:2001274 | immunoglobulin biosynthetic process(GO:0002378) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 1.6 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.2 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.3 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.1 | 0.5 | GO:0070945 | neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.2 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 1.6 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.3 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.3 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.1 | 0.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.3 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.1 | 0.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.3 | GO:0021836 | chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.1 | 0.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.1 | 0.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.4 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.4 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.2 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.1 | 0.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.2 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.5 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.3 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.1 | 0.4 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.2 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.8 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.4 | GO:0002423 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.1 | 2.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:0060300 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) regulation of cytokine activity(GO:0060300) |
0.1 | 0.1 | GO:0060775 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.1 | 0.4 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.3 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 1.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 0.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.1 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.1 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.9 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 1.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.3 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.1 | 1.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 0.2 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear migration along microfilament(GO:0031022) |
0.1 | 0.4 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.1 | 1.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.4 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.2 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.1 | 0.5 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.3 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.1 | 0.2 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.1 | 0.5 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.4 | GO:1901909 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 0.7 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.3 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.6 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.6 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 1.8 | GO:0010043 | response to zinc ion(GO:0010043) |
0.1 | 0.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.1 | 0.4 | GO:0014866 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.2 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.2 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.1 | 0.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.2 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.1 | 0.2 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.2 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.1 | 0.9 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.2 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
0.1 | 1.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.8 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.2 | GO:1904453 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.1 | 0.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.2 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.1 | 0.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.4 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.1 | 0.1 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.1 | 0.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 0.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.2 | GO:0050904 | diapedesis(GO:0050904) |
0.1 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.5 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
0.1 | 0.4 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.3 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.1 | 0.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.3 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 1.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.1 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.3 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.1 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 1.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.2 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.3 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.3 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.3 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.0 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.6 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.1 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.0 | 0.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.0 | 0.2 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.0 | 1.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.6 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.4 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.3 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.1 | GO:0019085 | early viral transcription(GO:0019085) |
0.0 | 0.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.4 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.7 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:0001192 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
0.0 | 0.6 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.7 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.1 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.0 | 0.2 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.0 | 0.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.0 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.0 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 1.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.3 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.0 | 0.1 | GO:1900150 | regulation of defense response to fungus(GO:1900150) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.0 | 0.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.0 | 0.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.9 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.3 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 1.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.2 | GO:0010813 | neuropeptide catabolic process(GO:0010813) dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.0 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.2 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.0 | 0.1 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.0 | 0.1 | GO:0036088 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.0 | 1.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.2 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.0 | 0.1 | GO:0042374 | menaquinone metabolic process(GO:0009233) phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.9 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.5 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 1.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.3 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.0 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.1 | GO:0048597 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.0 | 0.1 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.6 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.1 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.0 | 0.4 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.0 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.2 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.2 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.0 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 1.0 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.1 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
0.0 | 0.2 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.0 | 0.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.0 | 0.6 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.8 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.0 | 0.2 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.1 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.0 | 0.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 0.7 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.2 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 1.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 2.7 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.2 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
0.0 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.3 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.9 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0052205 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.1 | GO:0097105 | postsynaptic membrane assembly(GO:0097104) presynaptic membrane assembly(GO:0097105) |
0.0 | 0.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.2 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.0 | 0.1 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.2 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.0 | 0.2 | GO:0046864 | retinol transport(GO:0034633) nose morphogenesis(GO:0043585) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
0.0 | 0.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 0.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.1 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.0 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 1.7 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.4 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.1 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.0 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.1 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.0 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) negative regulation of glycogen catabolic process(GO:0045818) |
0.0 | 0.5 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.2 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.0 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.0 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.0 | 0.1 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.0 | 0.1 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.0 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.2 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.0 | 0.1 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.0 | 0.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 1.1 | GO:0031016 | pancreas development(GO:0031016) |
0.0 | 0.5 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.1 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.9 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.1 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.0 | 0.1 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.1 | GO:0032264 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.6 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.4 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.0 | 0.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.7 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.1 | GO:0055098 | response to lipoprotein particle(GO:0055094) response to low-density lipoprotein particle(GO:0055098) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.0 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.0 | 0.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.0 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.1 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.3 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.0 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.0 | 0.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.0 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.2 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.0 | 0.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.0 | 0.1 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.0 | 0.0 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.0 | 0.9 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.0 | 0.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.2 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.0 | 0.0 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.1 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.0 | 0.4 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.1 | GO:0021678 | third ventricle development(GO:0021678) |
0.0 | 0.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.0 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.0 | 0.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.1 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
0.0 | 0.0 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.0 | 0.0 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.0 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.0 | 0.1 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.1 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 1.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 0.8 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.3 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 1.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 2.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 2.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.7 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.2 | 4.8 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 0.9 | GO:0044393 | microspike(GO:0044393) |
0.2 | 1.0 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 3.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 1.8 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 2.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 1.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 1.0 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.4 | GO:0098855 | HCN channel complex(GO:0098855) |
0.1 | 0.5 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.1 | 1.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 2.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.3 | GO:0036019 | endolysosome(GO:0036019) |
0.1 | 0.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 1.3 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.3 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.1 | 0.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 1.7 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 1.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.3 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 1.3 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.2 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 0.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 1.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.5 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.4 | GO:0031673 | H zone(GO:0031673) |
0.1 | 1.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 2.0 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.6 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.2 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 0.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 0.3 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.1 | 0.2 | GO:1990795 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) photoreceptor cell terminal bouton(GO:1990796) |
0.1 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 1.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.5 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.2 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.7 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.6 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.9 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 1.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.4 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 1.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.0 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.5 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.2 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 1.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.0 | 2.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 3.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.0 | 0.1 | GO:0035841 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.0 | 0.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.8 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.0 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.0 | 0.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 27.8 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.4 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.7 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 2.4 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.9 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.2 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.0 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 1.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.4 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 4.0 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 1.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 2.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 4.4 | GO:0051870 | methotrexate binding(GO:0051870) |
0.4 | 2.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.4 | 1.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.4 | 1.1 | GO:0045352 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 receptor antagonist activity(GO:0005152) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
0.3 | 1.0 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.3 | 1.0 | GO:0047651 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.3 | 1.0 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.3 | 1.7 | GO:0055056 | dehydroascorbic acid transporter activity(GO:0033300) D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 1.7 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.3 | 0.9 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 0.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.3 | 1.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.3 | 0.8 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.3 | 2.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 0.8 | GO:0048030 | disaccharide binding(GO:0048030) |
0.3 | 3.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 1.0 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 1.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 1.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 0.5 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.2 | 3.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.7 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 2.7 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.7 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 0.6 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.2 | 0.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 0.6 | GO:0071820 | N-box binding(GO:0071820) |
0.2 | 1.4 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 0.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 0.6 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 1.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.9 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.2 | 0.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 1.5 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.2 | 0.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 0.5 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.2 | 2.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.8 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.9 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.6 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 4.0 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 1.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 2.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 1.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.7 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 3.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 1.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.5 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 2.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.5 | GO:0070976 | TIR domain binding(GO:0070976) |
0.1 | 1.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 4.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.5 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.3 | GO:0001034 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.1 | 0.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 1.5 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.5 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 0.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.3 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.1 | 0.7 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.3 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.1 | 0.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.5 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 1.1 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 0.3 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.1 | 0.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 0.3 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 2.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) IkappaB kinase activity(GO:0008384) K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 1.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.4 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.2 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.1 | 0.3 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 13.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 0.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.4 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.3 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 1.0 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.2 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.1 | 1.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 1.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 0.3 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.3 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.1 | 1.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 2.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.3 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.4 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.1 | 0.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 0.5 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
0.1 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.5 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.4 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.1 | 0.2 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.1 | 0.2 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.1 | 0.7 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.4 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.1 | 0.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.2 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.1 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 2.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 0.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.3 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 1.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.4 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 1.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 1.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.0 | 0.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.4 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 3.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 1.0 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 1.3 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.2 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.2 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.0 | 0.5 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.9 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 1.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.4 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.0 | 0.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.5 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.5 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 2.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.3 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.0 | 0.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.1 | GO:0047237 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.0 | 0.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.0 | 1.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.4 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.0 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.0 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 1.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.0 | 0.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.1 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.1 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
0.0 | 0.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.1 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.0 | 0.1 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.0 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.0 | 0.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0030977 | taurine binding(GO:0030977) |
0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.0 | 1.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.5 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.0 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 2.6 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 1.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.0 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.0 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.0 | 0.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.0 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.0 | 0.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.0 | 0.0 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.3 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 1.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.0 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.0 | 0.0 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 3.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 4.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 3.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 3.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 1.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 3.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 2.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 1.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 2.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 2.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.7 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 1.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 1.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 3.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 3.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 0.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 6.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 3.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 2.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 2.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 3.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 3.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.0 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 2.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 8.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 1.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 2.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 2.0 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.0 | 0.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 1.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 1.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.4 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 1.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.8 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 1.0 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.4 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |